Dr. D. CBD

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Sep
22
2018

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

The potential use of cannabidiol in the therapy of metabolic syndrome
Sep
20
2018

The potential use of cannabidiol in the therapy of metabolic syndrome

Is the cardiovascular system a therapeutic target for cannabidiol?
Sep
4
2018

Is the cardiovascular system a therapeutic target for cannabidiol?

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
May
28
2018

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.
May
27
2018

Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.

Nov
22
2017

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

Written by Dr D / Heart Attack
Nov
22
2017

Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress